Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Overview
Clinical & Translational Oncology is the official publication of the Federation of Spanish Oncology Societies and the National Cancer Institute of Mexico. This journal focuses on the latest advancements in clinical and translational research in the field of oncology. It provides a platform for scientists, clinicians, and researchers to share their findings, promote collaboration, and contribute to the improvement of cancer care and treatment.
Details
Details
Metrics
Metrics
h-index / Ranks: 6023
61
SJR / Ranks: 4929
837
CiteScore / Ranks: 3626
6.20
JIF / Ranks: 2884
3.4
Recent Articles
1.
2.
Benli Y, Arikan H, Akbulut-Caliskan O
Clin Transl Oncol
. 2025 Mar;
PMID: 40087250
Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer-related deaths worldwide. Despite treatment advancements in the last decades, CRC remains heterogeneous with significant...
3.
Alsurhi T, Shalaby A, Al-Sinawi S, Mabruk M
Clin Transl Oncol
. 2025 Mar;
PMID: 40080344
Background And Purpose: The expression of the hTERT component of the human telomerase is elevated in different types of malignancies, including skin cancer. Early diagnosis of malignant melanoma is necessary...
4.
Alsina Maqueda M, Teijo Quintans A, Cuatrecasas M, Fernandez Acenero M, Fernandez Montes A, Gomez Martin C, et al.
Clin Transl Oncol
. 2025 Mar;
PMID: 40072752
Gastroesophageal carcinomas, including gastroesophageal adenocarcinoma (GEA) and esophageal squamous cell carcinoma (ESCC), pose a global health challenge due to their heterogeneity. The approach to diagnosis and treatment should first differentiate...
5.
Torres-Tenor J, Bernal-Hertfelder E, Pertejo-Fernandez A, Ramon-Patino J, Redondo A, Alonso-Babarro A, et al.
Clin Transl Oncol
. 2025 Mar;
PMID: 40063332
Purpose: Assess the frequency of caregiver burden among patients with advanced cancer receiving palliative anticancer treatment. Compare characteristics of those who show caregiver burden versus those who do not. Methods/patients:...
6.
Ciniselli C, Verderio P, Duroni V, Baili P, Pizzamiglio S, de Braud F, et al.
Clin Transl Oncol
. 2025 Mar;
PMID: 40057925
Background: The reliability of core needle biopsy (CNB) for HER2-positive breast cancer is well established. However, data on HER2-low and the potential for inconsistencies with surgical samples are limited. Materials...
7.
Yang W, Long J, Li G, Xu J, Chen Y, Zhou S, et al.
Clin Transl Oncol
. 2025 Mar;
PMID: 40053252
Background: In lung adenocarcinoma (LUAD), there remains a dearth of efficacious diagnostic studies including some inflammation-related genes to identify the LUAD subgroups with different clinical outcomes. Methods: First, two molecular...
8.
Alterio D, Gola M, Zaffaroni M, Vincini M, Cattaneo C, Aristei C, et al.
Clin Transl Oncol
. 2025 Mar;
PMID: 40048019
Background: Human papilloma virus (HPV)-related cancers are well-known clinical entities in different body sites. Cervix, anus, and oropharynx are the most common tumors related to the virus infection. The aim...
9.
Yin J, Zhao Y, Yin J, Yang S
Clin Transl Oncol
. 2025 Mar;
PMID: 40042572
Background: Liver metastases from colorectal cancer are a common and serious complication that significantly impacts patient survival. The aim of this study is to investigate the clinical efficacy of transarterial...
10.
Paredes-Fernandez D, Lenz-Alcayaga R, Orlandi-Jorquera F
Clin Transl Oncol
. 2025 Mar;
PMID: 40025406
Purpose: Effective and sustainable treatments to improve patient outcomes are urgently needed for non-small cell lung carcinoma (NSCLC). Neoadjuvant therapies, particularly nivolumab, have shown superior outcomes in event-free survival and...